Analyst stock forecast
Cardiol Therapeutics Inc. - Class A Common Shares Stock Forecast and Analyst Price Target
CRDL analyst target range, upside, consensus rating and coverage count.
Direct answer
Cardiol Therapeutics Inc. - Class A Common Shares's average price target is $7.42.
The target implies +422.4% from the recorded current price, and the consensus rating is Strong Buy.
The verified range is $4.91 to $9.10, with 4 analysts in the current consensus when available.
Forecast evidence checked August 10, 2026.
Get free Cardiol Therapeutics Inc. - Class A Common Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.42
- Average price target
- $7.42
- High price target
- $9.10
- Low price target
- $4.91
- Target upside
- +422.4%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 10, 2026
- Valid through
- August 17, 2026
Explore related company data
View Cardiol Therapeutics Inc. - Class A Common Shares's price target rangeView Cardiol Therapeutics Inc. - Class A Common Shares's target upside or downsideView Cardiol Therapeutics Inc. - Class A Common Shares's analyst consensus ratingReturn to Cardiol Therapeutics Inc. - Class A Common Shares profile